These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30989171)

  • 21. Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
    Bilavsky E; Eliahou R; Keller N; Yarden-Bilavsky H; Harel L; Amir J
    J Infect; 2008 Apr; 56(4):244-8. PubMed ID: 18295897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four-Weekly Benzathine Penicillin G Provides Inadequate Protection against Acute Rheumatic Fever in Some Children.
    de Dassel JL; Malik H; Ralph AP; Hardie K; Remenyi B; Francis JR
    Am J Trop Med Hyg; 2019 May; 100(5):1118-1120. PubMed ID: 30915960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.
    Beaton A; Okello E; Rwebembera J; Grobler A; Engelman D; Alepere J; Canales L; Carapetis J; DeWyer A; Lwabi P; Mirabel M; Mocumbi AO; Murali M; Nakitto M; Ndagire E; Nunes MCP; Omara IO; Sarnacki R; Scheel A; Wilson N; Zimmerman M; Zühlke L; Karthikeyan G; Sable CA; Steer AC
    N Engl J Med; 2022 Jan; 386(3):230-240. PubMed ID: 34767321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatic fever prophylaxis in South Africa--is bicillin 1,2 million units every 4 weeks appropriate?
    Daniels ED; Mohanlal D; Pettifor JM
    S Afr Med J; 1994 Aug; 84(8 Pt 1):477-81. PubMed ID: 7825080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of rheumatic fever with multiple recurrences of carditis.
    Cetin II; Bikmaz YE; Varan B; Tokel K
    Turk J Pediatr; 2008; 50(2):186-8. PubMed ID: 18664087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of rheumatic fever prophylaxis regimens.
    Thamlikitkul V; Kobwanthanakun S; Pruksachatvuthi S; Lertluknithi R
    J Int Med Res; 1992 Feb; 20(1):20-6. PubMed ID: 1568517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks.
    Lue HC; Wu MH; Wang JK; Wu FF; Wu YN
    J Pediatr; 1994 Nov; 125(5 Pt 1):812-6. PubMed ID: 7965439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of benzathine penicillin G: A multinational cross-sectional study.
    Hand RM; Senarathna SMDKG; Page-Sharp M; Gray K; Sika-Paotonu D; Sheel M; Chuang VTG; Martinez J; Luna G; Manning L; Wyber R; Carapetis JR; Batty KT
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00668. PubMed ID: 33090729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children with rheumatic fever and controls.
    Lamas MC; Hilário MO; Francisco W; Goldenberg J; Naspitz CK
    J Investig Allergol Clin Immunol; 1992; 2(5):268-73. PubMed ID: 1342909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic efficiency of 3-weekly benzathine penicillin G in rheumatic fever.
    Oran B; Tastekin A; Karaaslan S; Bas L; Ayçiçek A; Ceri A; Sütçü A; Erkul I
    Indian J Pediatr; 2000 Mar; 67(3):163-7. PubMed ID: 10838716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.
    Kevat PM; Gunnarsson R; Reeves BM; Ruben AR
    J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How accurate is the diagnosis of rheumatic fever in Egypt? Data from the national rheumatic heart disease prevention and control program (2006-2018).
    Ghamrawy A; Ibrahim NN; Abd El-Wahab EW
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008558. PubMed ID: 32804953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1,200,000 units.
    Kaplan EL; Berrios X; Speth J; Siefferman T; Guzman B; Quesny F
    J Pediatr; 1989 Jul; 115(1):146-50. PubMed ID: 2738782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with loss of penicillin G concentrations in serum after intramuscular benzathine penicillin G injection: a meta-analysis.
    Broderick MP; Hansen CJ; Faix DJ
    Pediatr Infect Dis J; 2012 Jul; 31(7):722-5. PubMed ID: 22481428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RHD elimination: action needed beyond secondary prophylaxis.
    Hardie K; Ralph AP; de Dassel JL
    Aust N Z J Public Health; 2020 Oct; 44(5):427. PubMed ID: 32510810
    [No Abstract]   [Full Text] [Related]  

  • 38. Adherence to Benzathine Penicillin G Secondary Prophylaxis and Its Determinants in Patients with Rheumatic Heart Disease at a Cardiac Center of an Ethiopian Tertiary Care Teaching Hospital.
    Mekonen KK; Yismaw MB; Abiye AA; Tadesse TA
    Patient Prefer Adherence; 2020; 14():343-352. PubMed ID: 32110000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [5 years of recurrence prevention of rheumatic fever using benzathine penicillin].
    Menner K
    Med Welt; 1967 Nov; 45():2723-5. PubMed ID: 5609215
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.
    Wyber R; Boyd BJ; Colquhoun S; Currie BJ; Engel M; Kado J; Karthikeyan G; Sullivan M; Saxena A; Sheel M; Steer A; Mucumbitsi J; Zühlke L; Carapetis J
    Drug Deliv Transl Res; 2016 Oct; 6(5):572-8. PubMed ID: 27465618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.